Maxigen Biotech Inc.

TWSE:1783 Stock Report

Market Cap: NT$3.8b

Maxigen Biotech Balance Sheet Health

Financial Health criteria checks 6/6

Maxigen Biotech has a total shareholder equity of NT$1.3B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.6B and NT$236.5M respectively. Maxigen Biotech's EBIT is NT$124.9M making its interest coverage ratio -5.1. It has cash and short-term investments of NT$520.8M.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ratio-5.1x
CashNT$520.79m
EquityNT$1.33b
Total liabilitiesNT$236.54m
Total assetsNT$1.57b

Recent financial health updates

No updates

Recent updates

Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Mar 28
Maxigen Biotech's (TWSE:1783) Earnings Are Of Questionable Quality

Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

Apr 22
Maxigen Biotech Inc. (TPE:1783) Is Yielding 2.3% - But Is It A Buy?

We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Apr 01
We Think You Should Be Aware Of Some Concerning Factors In Maxigen Biotech's (TPE:1783) Earnings

Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 16
Maxigen Biotech Inc.'s (TPE:1783) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Feb 23
The Maxigen Biotech (TPE:1783) Share Price Has Gained 22% And Shareholders Are Hoping For More

Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Feb 02
Can Maxigen Biotech (TPE:1783) Continue To Grow Its Returns On Capital?

Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Jan 10
Tread With Caution Around Maxigen Biotech Inc.'s (TPE:1783) 3.4% Dividend Yield

Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

Dec 14
Declining Stock and Decent Financials: Is The Market Wrong About Maxigen Biotech Inc. (TPE:1783)?

If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Nov 22
If You Had Bought Maxigen Biotech's (TPE:1783) Shares Five Years Ago You Would Be Down 13%

Financial Position Analysis

Short Term Liabilities: 1783's short term assets (NT$728.6M) exceed its short term liabilities (NT$235.6M).

Long Term Liabilities: 1783's short term assets (NT$728.6M) exceed its long term liabilities (NT$942.0K).

Debt to Equity History and Analysis

Debt Level: 1783 is debt free.

Reducing Debt: 1783 has no debt compared to 5 years ago when its debt to equity ratio was 26%.

Debt Coverage: 1783 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 1783 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y